Patents by Inventor Jonas Soderholm

Jonas Soderholm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNOGEN PLATFORM
    Publication number: 20170058003
    Abstract: Aspects of the present invention relate to chimeric polypeptides including HCV NS3/4A sequences and T-cell epitopes. Embodiments include nucleic acids encoding the chimeric NS3/4A polypeptides, the encoded polypeptides, compositions containing said nucleic acids, compositions containing said chimeric polypeptides, as well as methods of making and using the aforementioned compositions including, but not limited to medicaments and vaccines.
    Type: Application
    Filed: April 7, 2016
    Publication date: March 2, 2017
    Inventors: Matti Sällberg, Jonas Soderholm, Lars Frelin
  • IMMUNOGEN PLATFORM
    Publication number: 20150051388
    Abstract: Aspects of the present invention relate to chimeric polypeptides including HCV NS3/4A sequences and T-cell epitopes. Embodiments include nucleic acids encoding the chimeric NS3/4A polypeptides, the encoded polypeptides, compositions containing said nucleic acids, compositions containing said chimeric polypeptides, as well as methods of making and using the aforementioned compositions including, but not limited to medicaments and vaccines.
    Type: Application
    Filed: October 29, 2014
    Publication date: February 19, 2015
    Inventors: Matti Sällberg, Jonas Soderholm, Lars Frelin
  • Immunogen platform
    Patent number: 8883169
    Abstract: Aspects of the present invention relate to chimeric polypeptides including HCV NS3/4A sequences and T-cell epitopes. Embodiments include nucleic acids encoding the chimeric NS3/4A polypeptides, the encoded polypeptides, compositions containing said nucleic acids, compositions containing said chimeric polypeptides, as well as methods of making and using the aforementioned compositions including, but not limited to medicaments and vaccines.
    Type: Grant
    Filed: July 7, 2011
    Date of Patent: November 11, 2014
    Assignee: Chrontech Pharma AB
    Inventors: Matti Sällberg, Jonas Soderholm, Lars Frelin
  • Immunogen platform
    Patent number: 8258275
    Abstract: Aspects of the present invention relate to chimeric polypeptides including HCV NS3/4A sequences and T-cell epitopes. Embodiments include nucleic acids encoding the chimeric NS3/4A polypeptides, the encoded polypeptides, compositions containing said nucleic acids, compositions containing said chimeric polypeptides, as well as methods of making and using the aforementioned compositions including, but not limited to medicaments and vaccines.
    Type: Grant
    Filed: January 19, 2011
    Date of Patent: September 4, 2012
    Assignee: Chrontech Pharma AB
    Inventors: Matti Sällberg, Jonas Soderholm, Lars Frelin
  • IMMUNOGEN PLATFORM
    Publication number: 20120010394
    Abstract: Aspects of the present invention relate to chimeric polypeptides including HCV NS3/4A sequences and T-cell epitopes. Embodiments include nucleic acids encoding the chimeric NS3/4A polypeptides, the encoded polypeptides, compositions containing said nucleic acids, compositions containing said chimeric polypeptides, as well as methods of making and using the aforementioned compositions including, but not limited to medicaments and vaccines.
    Type: Application
    Filed: July 7, 2011
    Publication date: January 12, 2012
    Applicant: CHRONTECH PHARMA AB
    Inventors: Matti Sällberg, Jonas Soderholm, Lars Frelin
  • Immunogen platform
    Patent number: 8071561
    Abstract: Aspects of the present invention relate to chimeric polypeptides including HCV NS3/4A sequences and T-cell epitopes. Embodiments include nucleic acids encoding the chimeric NS3/4A polypeptides, the encoded polypeptides, compositions containing said nucleic acids, compositions containing said chimeric polypeptides, as well as methods of making and using the aforementioned compositions including, but not limited to medicaments and vaccines.
    Type: Grant
    Filed: August 15, 2008
    Date of Patent: December 6, 2011
    Assignee: ChronTech Pharma AB
    Inventors: Matti Sallberg, Jonas Soderholm, Lars Frelin
  • IMMUNOGEN PLATFORM
    Publication number: 20110150922
    Abstract: Aspects of the present invention relate to chimeric polypeptides including HCV NS3/4A sequences and T-cell epitopes. Embodiments include nucleic acids encoding the chimeric NS3/4A polypeptides, the encoded polypeptides, compositions containing said nucleic acids, compositions containing said chimeric polypeptides, as well as methods of making and using the aforementioned compositions including, but not limited to medicaments and vaccines.
    Type: Application
    Filed: January 19, 2011
    Publication date: June 23, 2011
    Applicant: ChronTech Pharma AB
    Inventors: Matti Sällberg, Jonas Soderholm, Lars Frelin
  • IMMUNOGEN PLATFORM
    Publication number: 20090214593
    Abstract: Aspects of the present invention relate to chimeric polypeptides including HCV NS3/4A sequences and T-cell epitopes. Embodiments include nucleic acids encoding the chimeric NS3/4A polypeptides, the encoded polypeptides, compositions containing said nucleic acids, compositions containing said chimeric polypeptides, as well as methods of making and using the aforementioned compositions including, but not limited to medicaments and vaccines.
    Type: Application
    Filed: February 16, 2009
    Publication date: August 27, 2009
    Applicant: TRIPEP AB
    Inventors: Matti Sallberg, Jonas Soderholm, Lars Frelin
  • IMMUNOGEN PLATFORM
    Publication number: 20090074803
    Abstract: Aspects of the present invention relate to chimeric polypeptides including HCV NS3/4A sequences and T-cell epitopes. Embodiments include nucleic acids encoding the chimeric NS3/4A polypeptides, the encoded polypeptides, compositions containing said nucleic acids, compositions containing said chimeric polypeptides, as well as methods of making and using the aforementioned compositions including, but not limited to medicaments and vaccines.
    Type: Application
    Filed: August 15, 2008
    Publication date: March 19, 2009
    Applicant: Tripep AB
    Inventors: Matti Sallberg, Jonas Soderholm, Lars Felin